{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T02:54:00Z","timestamp":1762138440951,"version":"build-2065373602"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU62PS924776"],"award-info":[{"award-number":["NU62PS924776"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR002370"],"award-info":[{"award-number":["KL2TR002370"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10461-025-04819-3","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T10:06:37Z","timestamp":1752141997000},"page":"3822-3829","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changes in the PrEP Care Cascade in People Who Inject Drugs in 2018 and 2022"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-1836","authenticated-orcid":false,"given":"Hunter C.","family":"Spencer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9541-0624","authenticated-orcid":false,"given":"Matthew A.","family":"Town","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5522-6715","authenticated-orcid":false,"given":"LaLaine","family":"Sevillano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8732-6403","authenticated-orcid":false,"given":"Lauren","family":"Lipira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4154-7718","authenticated-orcid":false,"given":"Tim W.","family":"Menza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"4819_CR1","unstructured":"Centers for Disease Control and Prevention, Estimated HIV incidence and prevalence in the United States, 2018\u20132022., HV Surveillance Supplemental Report, vol. 29(1), 2024."},{"issue":"5","key":"4819_CR2","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s10461-020-02988-x","volume":"25","author":"CB Mistler","year":"2021","unstructured":"Mistler CB, Copenhaver MM, Shrestha R. The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: a systematic review, (in eng). AIDS Behav. 2021;25(5):1490\u2013506. https:\/\/doi.org\/10.1007\/s10461-020-02988-x.","journal-title":"AIDS Behav"},{"key":"4819_CR3","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.15585\/mmwr.mm6446a4","volume":"64","author":"D Smith","year":"2015","unstructured":"Smith D, et al. Vital Signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition-United States 2015. MMWR Morbidity Mortality Weekly Rep. 2015;64:1291\u20135. https:\/\/doi.org\/10.15585\/mmwr.mm6446a4.","journal-title":"MMWR Morbidity Mortality Weekly Rep"},{"issue":"2","key":"4819_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11904-018-0390-3","volume":"15","author":"DC Perlman","year":"2018","unstructured":"Perlman DC, Jordan AE. The syndemic of opioid misuse, overdose, HCV, and HIV: structural-level causes and interventions (in eng). Curr HIV\/AIDS Rep. 2018;15(2):96\u2013112. https:\/\/doi.org\/10.1007\/s11904-018-0390-3.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"10072","key":"4819_CR5","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S0140-6736(17)30003-X","volume":"389","author":"M Singer","year":"2017","unstructured":"Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. The lancet. 2017;389(10072):941\u201350.","journal-title":"The lancet"},{"key":"4819_CR6","doi-asserted-by":"publisher","first-page":"105779","DOI":"10.1016\/j.ypmed.2019.105779","volume":"126","author":"KA Brookmeyer","year":"2019","unstructured":"Brookmeyer KA, Haderxhanaj LT, Hogben M, Leichliter J. Sexual risk behaviors and STDs among persons who inject drugs: a national study, (in eng). Prev Med. 2019;126:105779. https:\/\/doi.org\/10.1016\/j.ypmed.2019.105779.","journal-title":"Prev Med"},{"issue":"9883","key":"4819_CR7","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/s0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial, (in eng). Lancet. 2013;381(9883):2083\u201390. https:\/\/doi.org\/10.1016\/s0140-6736(13)61127-7.","journal-title":"Lancet"},{"issue":"8","key":"4819_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2023.9865","volume":"330","author":"R Chou","year":"2023","unstructured":"Chou R, Spencer H, Bougatsos C, Blazina I, Ahmed A, Selph S. Preexposure prophylaxis for the prevention of HIV: updated evidence report and systematic review for the US preventive services task force (in eng). JAMA. 2023;330(8):746\u201363. https:\/\/doi.org\/10.1001\/jama.2023.9865.","journal-title":"JAMA"},{"issue":"8","key":"4819_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jama.2023.14461","volume":"330","author":"US Preventive Services Task Force","year":"2023","unstructured":"US Preventive Services Task Force. Preexposure prophylaxis to prevent acquisition of HIV: US preventive services task force recommendation statement. JAMA. 2023;330(8):736\u201345. https:\/\/doi.org\/10.1001\/jama.2023.14461.","journal-title":"JAMA"},{"key":"4819_CR10","unstructured":"Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142021 Update: a clinical practice guideline. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2021.pdf. (accessed 10\/4\/2023, 2023)."},{"issue":"10","key":"4819_CR11","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1007\/s10461-019-02573-x","volume":"23","author":"C Zhang","year":"2019","unstructured":"Zhang C, McMahon J, Simmons J, Brown LL, Nash R, Liu Y. Suboptimal HIV pre-exposure prophylaxis awareness and willingness to use among women who use drugs in the united states: a systematic review and meta-analysis, (in eng). AIDS Behav. 2019;23(10):2641\u201353. https:\/\/doi.org\/10.1007\/s10461-019-02573-x.","journal-title":"AIDS Behav"},{"issue":"9","key":"4819_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343","volume":"321","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the united states. JAMA. 2019;321(9):844\u20135. https:\/\/doi.org\/10.1001\/jama.2019.1343.","journal-title":"JAMA"},{"issue":"5","key":"4819_CR13","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1007\/s10461-019-02682-7","volume":"24","author":"W McFarland","year":"2020","unstructured":"McFarland W, Lin J, Santos GM, Arayasirikul S, Raymond HF, Wilson E. Low PrEP awareness and use among people who inject drugs, San Francisco, 2018 (in eng). AIDS Behav. 2020;24(5):1290\u20133. https:\/\/doi.org\/10.1007\/s10461-019-02682-7.","journal-title":"AIDS Behav"},{"key":"4819_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-024-04308-z","author":"B Suprasert","year":"2024","unstructured":"Suprasert B, et al. Continuing low awareness and use of pre-exposure prophylaxis (PrEP) for HIV among people who inject drugs (PWID), San Francisco, 2022 (in eng). AIDS Behav. 2024. https:\/\/doi.org\/10.1007\/s10461-024-04308-z.","journal-title":"AIDS Behav"},{"key":"4819_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000004005","author":"PC Eustaquio","year":"2022","unstructured":"Eustaquio PC, Burnett J, Prejean J, Chapin-Bardales J, Cha S. Changes in HIV pre-exposure prophylaxis awareness and use among males who inject drugs who have sex with men by sexual identity, 19 US Urban Areas, 2018 (in eng). Aids. 2022. https:\/\/doi.org\/10.1097\/qad.0000000000004005.","journal-title":"Aids"},{"issue":"7","key":"4819_CR16","doi-asserted-by":"publisher","first-page":"e2221346","DOI":"10.1001\/jamanetworkopen.2022.21346","volume":"5","author":"CG Streed Jr","year":"2022","unstructured":"Streed CG Jr, Morgan JR, Gai MJ, Larochelle MR, Paasche-Orlow MK, Taylor JL. Prevalence of HIV preexposure prophylaxis prescribing among persons with commercial insurance and likely injection drug use. JAMA Netw Open. 2022;5(7):e2221346\u2013e2221346. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.21346.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"4819_CR17","doi-asserted-by":"publisher","first-page":"e2431612","DOI":"10.1001\/jamanetworkopen.2024.31612","volume":"7","author":"MJ Zoorob","year":"2024","unstructured":"Zoorob MJ, Park JN, Kral AH, Lambdin BH, Del Pozo B. Drug decriminalization, fentanyl, and fatal overdoses in Oregon (in eng). JAMA Netw Open. 2024;7(9):e2431612. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.31612.","journal-title":"JAMA Netw Open"},{"key":"4819_CR18","unstructured":"(2021). National HIV Behavioral Surveillance System Round 6: Model Surveillance Protocol. [Online] Available: www.cdc.gov\/hiv\/statistics\/systems\/nhbs\/operations.html."},{"issue":"11","key":"4819_CR19","doi-asserted-by":"publisher","first-page":"e39053","DOI":"10.2196\/39053","volume":"8","author":"D Kanny","year":"2022","unstructured":"Kanny D, Broz D, Finlayson T, Lee K, Sionean C, Wejnert C. A key comprehensive system for biobehavioral surveillance of populations disproportionately affected by HIV (National HIV Behavioral Surveillance): Cross-sectional Survey Study, (in eng). JMIR Public Health Surveill. 2022;8(11):e39053. https:\/\/doi.org\/10.2196\/39053.","journal-title":"JMIR Public Health Surveill"},{"issue":"8","key":"4819_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/09564624231154302","volume":"34","author":"HC Spencer","year":"2023","unstructured":"Spencer HC, Babiarz J, Menza TW. Human immunodeficiency virus pre-exposure prophylaxis awareness among people who inject drugs in Portland, Oregon, (in eng). Int J STD AIDS. 2023;34(8):567\u201373. https:\/\/doi.org\/10.1177\/09564624231154302.","journal-title":"Int J STD AIDS"},{"key":"4819_CR21","unstructured":"Stata Statistical Software: Release 18.5. (2023). StataCorp LLC."},{"key":"4819_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-024-04285-3","author":"WH Eger","year":"2024","unstructured":"Eger WH, et al. Long-acting injectable PrEP interest and general PrEP awareness among people who inject drugs in the San Diego-Tijuana border metroplex (in eng). AIDS Behav. 2024. https:\/\/doi.org\/10.1007\/s10461-024-04285-3.","journal-title":"AIDS Behav"},{"key":"4819_CR23","doi-asserted-by":"publisher","first-page":"108058","DOI":"10.1016\/j.jsat.2020.108058","volume":"117","author":"R Shrestha","year":"2020","unstructured":"Shrestha R, DiDomizio EE, Kim RS, Altice FL, Wickersham JA, Copenhaver MM. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs, (in eng). J Subst Abuse Treat. 2020;117:108058. https:\/\/doi.org\/10.1016\/j.jsat.2020.108058.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"4819_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1186\/s12879-022-07572-3","volume":"22","author":"AR King","year":"2022","unstructured":"King AR, Shah S, Randall LA, Frew PM, Spaulding A, Holloway IW. Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings (in eng). BMC Infect Dis. 2022;22(1):737. https:\/\/doi.org\/10.1186\/s12879-022-07572-3.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"4819_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/09540121.2023.2288646","volume":"36","author":"JS Lee","year":"2024","unstructured":"Lee JS, et al. Structural vulnerabilities and PrEP awareness among Boston heterosexuals and people who inject drugs at risk for HIV: findings from 2018 to 2019 cycles from the Boston, MA site of the NHBS, (in eng). AIDS Care. 2024;36(5):641\u201351. https:\/\/doi.org\/10.1080\/09540121.2023.2288646.","journal-title":"AIDS Care"},{"issue":"3","key":"4819_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/10826084.2021.2012688","volume":"57","author":"MA Corcorran","year":"2022","unstructured":"Corcorran MA, Scott JD, Tinsley J, Wald A, Glick SN. Awareness and correlates of HIV pre-exposure prophylaxis (PrEP) among HIV-negative people who access syringe services in Seattle, Washington (in eng). Subst Use Misuse. 2022;57(3):337\u201343. https:\/\/doi.org\/10.1080\/10826084.2021.2012688.","journal-title":"Subst Use Misuse"},{"issue":"7","key":"4819_CR27","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s10461-018-2293-0","volume":"23","author":"A Roth","year":"2019","unstructured":"Roth A, Tran N, Piecara B, Welles S, Shinefeld J, Brady K. Factors associated with awareness of pre-exposure prophylaxis for HIV among persons who inject drugs in Philadelphia: national HIV behavioral surveillance, 2015 (in eng). AIDS Behav. 2019;23(7):1833\u201340. https:\/\/doi.org\/10.1007\/s10461-018-2293-0.","journal-title":"AIDS Behav"},{"issue":"5","key":"4819_CR28","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s10461-020-03141-4","volume":"25","author":"A Seaman","year":"2021","unstructured":"Seaman A, et al. Harm reduction and adaptations among PWUD in rural Oregon during COVID-19, (in eng). AIDS Behav. 2021;25(5):1331\u20139. https:\/\/doi.org\/10.1007\/s10461-020-03141-4.","journal-title":"AIDS Behav"},{"key":"4819_CR29","doi-asserted-by":"publisher","first-page":"205032452311674","DOI":"10.1177\/20503245231167407","volume":"9","author":"K Russoniello","year":"2023","unstructured":"Russoniello K, et al. Decriminalization of drug possession in Oregon: analysis and early lessons. Drug Sci Policy Law. 2023;9:20503245231167410. https:\/\/doi.org\/10.1177\/20503245231167407.","journal-title":"Drug Sci Policy Law"},{"issue":"6","key":"4819_CR30","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s10461-021-03522-3","volume":"26","author":"J Walters","year":"2022","unstructured":"Walters J, et al. Use of injection drugs and any form of methamphetamine in the Portland, OR metro area as a driver of an HIV time-space cluster: Clackamas, Multnomah, and Washington Counties, 2018\u20132020, (in eng). AIDS Behav. 2022;26(6):1717\u201326. https:\/\/doi.org\/10.1007\/s10461-021-03522-3.","journal-title":"AIDS Behav"},{"key":"4819_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","volume":"44","author":"D Heckathorn","year":"1997","unstructured":"Heckathorn D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Problems. 1997;44:174\u201399. https:\/\/doi.org\/10.2307\/3096941.","journal-title":"Soc Problems"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04819-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04819-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04819-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T02:49:17Z","timestamp":1762138157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04819-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4819"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04819-3","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"type":"print","value":"1090-7165"},{"type":"electronic","value":"1573-3254"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"26 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interests (or competing interests).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Oregon Health Authority\u2019s Science and Epidemiology Council and the Human Subjects Research Review Committee at Portland State University deemed NHBS to be public health surveillance and therefore exempt from review. All participants represented in this study consented to participate and to have their data used in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}}]}}